New Delhi, June 12 -- The US Food and Drug Administration (FDA) has issued an import alert for drugs manufactured at Dabur India's factory in Dadra and Nagar Haveli following an inspection, the consumer goods company said on Thursday.

The action was taken after the FDA inspected ⁠the factory and flagged data integrity and maintenance lapses.

Last month, Reuters reported citing the inspection report that the regulator found critical manufacturing ​records were falsified to conceal that equipment meant to make certain products had been used for multiple other products.

A live bird and bird droppings were found in the raw material warehouse, about ​30 feet from packaging materials.

A product placed on an FDA import aler...